Chengzhong Ye

Chengzhong Ye

Auto-generated profile, based on publicly available information

Chengzhong Ye

School of Medicine, Tsinghua University, Beijing, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2018 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
K(Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab)
Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab)
PSPeter Savas
Peter Savas
BVBalaji Virassamy
Balaji Virassamy
CYChengzhong Ye
Chengzhong Ye
ASAgus Salim
Agus Salim
SLSherene Loi
Sherene Loi

30 August 2019 in Nature Methods
Verified
Journal Article
Closed access
PDF file
JWJingshu Wang
Jingshu Wang
DADivyansh Agarwal
Divyansh Agarwal
MHMo Huang
Mo Huang
GHGang Hu
Gang Hu
ZZZilu Zhou
Zilu Zhou
NZNancy R. Zhang
Nancy R. Zhang

31 January 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZZZilu Zhou
Zilu Zhou
CYChengzhong Ye
Chengzhong Ye
JWJingshu Wang
Jingshu Wang
NZNancy R. Zhang
Nancy R. Zhang
While single cell RNA sequencing (scRNA-seq) is invaluable for studying cell populations, cell-surface proteins are often integral markers of cellular function and serve as primary targets for therapeutic intervention. Here we propose a transfer learning framework, single cell Transcriptome to Protein prediction with deep neural network (cTP-net), to impute surface protein abundances from scRNA-seq data by learning from existing single-cell multi-omic resources.

14 June 2019 in Bioinformatics
Verified
Journal Article
Open access
PDF file
CYChengzhong Ye
Chengzhong Ye
TSTerence P Speed
Terence P Speed
ASAgus Salim
Agus Salim
Dropout is a common phenomenon in single-cell RNA-seq (scRNA-seq) data, and when left unaddressed it affects the validity of the statistical analyses. Despite this, few current methods for differential expression (DE) analysis of scRNA-seq data explicitly model the process that gives rise to the dropout events. We develop DECENT, a method for DE analysis of scRNA-seq data that explicitly and accurately models the molecule capture process in scRNA-seq experiments. We show that DECENT demonstrates improved DE performance over existing DE methods that do not explicitly model dropout. This improvement is consistently observed across several public scRNA-seq datasets generated using different technological platforms. The gain in improvement is especially large when the capture process is overdispersed. DECENT maintains type I error well while achieving better sensitivity. Its performance without spike-ins is almost as good as when spike-ins are used to calibrate the capture model. The method is implemented as a publicly available R package available from https://github.com/cz-ye/DECENT. Supplementary data are available at Bioinformatics online.

17 November 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
MJMilind Jagota
Milind Jagota
CYChengzhong Ye
Chengzhong Ye
CACarlos Albors
Carlos Albors
RRRuchir Rastogi
Ruchir Rastogi
AKAntoine Koehl
Antoine Koehl
YSYun S. Song
Yun S. Song
Genetic variation in the human genome is a major determinant of individual disease risk, but the vast majority of missense variants have unknown etiological effects. Here, we present a robust learning framework for leveraging saturation mutagenesis experiments to construct accurate computational predictors of proteome-wide missense variant pathogenicity. We train cross-protein transfer (CPT) models using deep mutational scanning data from only five proteins and achieve state-of-the-art performance on clinical variant interpretation for unseen proteins across the human proteome. High sensitivity is crucial for clinical applications and our model CPT-1 particularly excels in this regime. For instance, at 95% sensitivity of detecting human disease variants annotated in ClinVar, CPT-1 improves specificity to 68%, from 27% for ESM-1v and 55% for EVE. Furthermore, for genes not used to train REVEL, a supervised method widely used by clinicians, we show that CPT-1 compares favorably with REVEL. Our framework combines predictive features derived from general protein sequence models, vertebrate sequence alignments, and AlphaFold2 structures, and it is adaptable to the future inclusion of other sources of information. We find that vertebrate alignments, albeit rather shallow with only 100 genomes, provide a strong signal for variant pathogenicity prediction that is complementary to recent deep learning-based models trained on massive amounts of protein sequence data. We release predictions for all possible missense variants in 90% of human genes. Our results demonstrate the utility of mutational scanning data for learning properties of variants that transfer to unseen proteins.